67436 Federal Register / Vol. 79, No. 219 / Thursday, November 13, 2014 / Notices 

1 In particular, the written request for confidential 

treatment that accompanies the comment must 

include the factual and legal basis for the request, 

and must identify the specific portions of the 

comment to be withheld from the public record. See 

FTC Rule 4.9(c), 16 CFR 4.9(c). 

manufacturing processes, or customer 

names. 

If you want the Commission to give 

your comment confidential treatment, 

you must file it in paper form, with a 

request for confidential treatment, and 

you have to follow the procedure 

explained in FTC Rule 4.9(c), 16 CFR 

4.9(c).1 Your comment will be kept 

confidential only if the FTC General 

Counsel, in his or her sole discretion, 

grants your request in accordance with 

the law and the public interest. 

Postal mail addressed to the 

Commission is subject to delay due to 

heightened security screening. As a 

result, we encourage you to submit your 

comments online. To make sure that the 

Commission considers your online 

comment, you must file it at https://

ftcpublic.commentworks.com/ftc/

mphjtechconsent by following the 

instructions on the web-based form. If 

this Notice appears at http://

www.regulations.gov/#!home, you also 

may file a comment through that Web 

site. 

If you file your comment on paper, 

write ‘‘MPHJ Technology Investments, 

LLC, et al—Consent Agreement; File No. 

142 3003’’ on your comment and on the 

envelope, and mail your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW., Suite 

CC–5610 (Annex D), Washington, DC 

20580, or deliver your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW., 

5th Floor, Suite 5610 (Annex D), 

Washington, DC 20024. If possible, 

submit your paper comment to the 

Commission by courier or overnight 

service. 

Visit the Commission Web site at 

http://www.ftc.gov to read this Notice 

and the news release describing it. The 

FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before December 8, 2014. You can find 

more information, including routine 

uses permitted by the Privacy Act, in 

the Commission’s privacy policy, at 

http://www.ftc.gov/ftc/privacy.htm. 

Analysis of Proposed Consent Order To 

Aid Public Comment 

The Federal Trade Commission (the 

‘‘Commission’’) has accepted, subject to 

approval, an agreement containing a 

consent order from MPHJ Technology 

Investments, LLC; Jay Mac Rust; and 

Farney Daniels, P.C. (the 

‘‘Respondents’’). 

The proposed consent order has been 

placed on the public record for thirty 

(30) days for receipt of comments by 

interested persons. Comments received 

during this period will become part of 

the public record. After thirty days, the 

Commission will again review the 

agreement and the comments received, 

and will decide whether it should 

withdraw from the agreement and take 

appropriate action or make final the 

agreement’s proposed order. 

This matter concerns allegedly 

deceptive representations that the 

Respondents made in a campaign of 

letters sent to thousands of small 

businesses across the United States in 

an attempt to sell licenses for certain 

U.S. patents. The complaint alleges that 

the Respondents made false or 

unsubstantiated representations in their 

letters that many small businesses had 

already agreed to pay thousands of 

dollars for such licenses. The complaint 

also alleges that the Respondents’ letters 

falsely represented that a patent 

infringement lawsuit would be filed 

against the recipient if it did not 

respond to the letter, and that this suit 

would be filed imminently. The 

complaint alleges that these 

representations constitute deceptive acts 

or practices in violation of Section 5 of 

the Federal Trade Commission Act. 

The proposed consent order contains 

provisions designed to prevent the 

Respondents from engaging in similar 

acts and practices in the future. Section 

I.A of the proposed order would 

prohibit false or unsubstantiated 

representations that a patent has been 

licensed in substantial numbers, at 

particular prices, or within particular 

price ranges. Section I.B of the proposed 

order would prohibit false or 

unsubstantiated representations about 

the licenses for a patent or the responses 

of recipients of patent assertion 

communications, or concerning the 

results of licensing, sales, settlement, or 

litigation of a patent. Section I.C would 

prohibit misrepresentations that the 

Respondents or an affiliate of the 

Respondents has initiated a lawsuit. 

And Section I.D would prohibit 

representations that the Respondents or 

an affiliate of the Respondents will 

initiate a lawsuit unless they have 

decided to take such action and they 

possess competent and reliable evidence 

sufficient to substantiate that they are 

prepared and able to do so. In 

determining whether such a 

representation was substantiated at the 

time that it was made, evidence that an 

action was not taken because of a 

change in circumstances or information 

obtained subsequent to making the 

representation shall be considered. 

These prohibitions in the proposed 

consent order apply to communications 

(other than filings in a lawsuit or 

correspondence between counsel in a 

lawsuit) that state that the intended 

recipient or anyone affiliated with the 

intended recipient is or may be 

infringing rights arising from a patent, is 

or may be obligated to obtain a license 

because of a patent, or owes or may owe 

compensation to another because of a 

patent. 

The proposed consent order also 

contains reporting and compliance 

provisions. Section II requires the 

Respondents to maintain and upon 

request make available certain 

compliance-related records. Sections III 

through VI requires the Respondents to 

deliver a copy of the order to officers, 

employees, and representatives having 

managerial responsibilities with respect 

to the order’s subject matter, notify the 

Commission of changes in corporate 

structure that might affect compliance 

obligations, and file compliance reports 

with the Commission. 

Section VII of the proposed order 

provides that, with certain exceptions, 

the order will terminate in twenty years. 

The purpose of this analysis is to 

facilitate public comment on the 

proposed order. It is not intended to 

constitute an official interpretation of 

the complaint or the proposed order, or 

to modify in any way the proposed 

order’s terms. 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. 2014–26803 Filed 11–12–14; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Intent To Award Ebola 

Response Outbreak Funding to the 

International Association of National 

Public Health Institutes (IANPHI) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 219 / Thursday, November 13, 2014 / Notices 67437 

ACTION: Notice. 

SUMMARY: This notice provides public 

announcement of CDC’s intent to award 

Ebola appropriations to the 

International Association of National 

Public Health Institutes (IANPHI) for 

response to the Ebola outbreak funding. 

This award was proposed in Fiscal Year 

(FY) 2015 under funding opportunity 

announcement GH14–1419 ‘‘Advancing 

National Public Health Institutes 

Globally’’. IANPHI is uniquely 

positioned, in terms of authority, ability, 

track record, infrastructure, and 

credibility to engage its member 

institutes to respond to the Ebola 

outbreak in West Africa. Furthermore, 

these activities to increase eligible 

governments’ capacity to respond to the 

Ebola outbreak are directly aligned with 

the current activities that IANPHI is 

conducting under this FOA to 

strengthen and expand national public 

health institute capabilities and support 

global health security. 

Catalogue of Federal Domestic Assistance 

Number (CFDA): 93.318. 

Authority: Sections 307 and 317(k)(2), 

Public Health Service Act 42 U.S.C. 242l and 

247b(k)(2) as amended. 

Single award may be awarded to 

grantee totaling $1,100,000 for Ebola 

response outbreak. 

Funding is appropriated under the 

Continuing Appropriations Resolution, 

2015, Public Law 113–164, 128 Stat. 

1867 (2014). 

DATES: Anticipated award date is 12/1/ 

2014. 

Application Due Date: 11/17/2014. 

Project Number is CDC–RFA–GH14– 

1419. 

ADDRESSES: CDC has waived the 

Grants.gov electronic submission 

process for this requirement. Recipients 

are hereby authorized to submit a paper 

copy application for (CDC–RFA–GH14– 

1419) via Express Mail (i.e. FedEx, UPS, 

or DHL) and send the application via 

email. Mailed applications must be 

address to Dionne Bounds, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

telephone (770) 488–2082, or email her 

at DBounds@cdc.gov. The application 

must include a detailed line-item budget 

and justification to support the Ebola 

activities from December 1, 2014 to 

September 29, 2015. 

Please download the following to 

complete the application package: 

http://apply07.grants.gov/apply/forms/

sample/SF424_2_1-V2.1.pdf— 

Application Package 

http://www.cdc.gov/od/pgo/funding/

docs/CertificationsForm.pdf— 

Certifications 

http://www.cdc.gov/od/pgo/funding/

grants/foamain.shtm—Assurances 

http://www.cdc.gov/od/pgo/funding/

grants/Budget_Preparation_

Guidelines_8-2-12.docx—CDC–PGO 

Budget Guidelines 

http://apply07.grants.gov/apply/forms/

sample/SF424A-V1.0.pdf—SF–424A 

Budget Information 

All applications must be submitted to 

and received by the Grants Management 

Officer (GMO) no later than 11:59 p.m. 

EST on November 17, 2014 and please 

provide the GMO a PDF version of the 

application by email to the following 

email address: ogsghsebolaresponse@

cdc.gov subject line: CDC–RFA–GH14– 

1419. 

Applicants will be provided with the 

Funding Opportunity Announcement 

(FOA) and additional application 

submission guidance via email 

notification. Applicants may contact the 

POCs listed with questions regarding 

the application process. 

FOR FURTHER INFORMATION CONTACT: 

For programmatic or technical 

assistance: Miranda Bodfish, Project 

Officer, Department of Health and 

Human Services, Centers for Disease 

Control and Prevention, 1600 Clifton 

Rd. MS E–93, Atlanta, GA 30333, 

Telephone: 404 719–0232, email: 

WTI4@cdc.gov. 

For financial, awards management, or 

budget assistance: Dionne Bounds, 

Grants Management Officer, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

Telephone (770) 488- 2082, email: 

DBounds@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

purpose of this notice is to solicit an 

application from IANPHI to assist in the 

response to the Ebola virus in West 

Africa. The funding will support the 

impacted surrounding countries to 

combat this health crisis. This funding 

will target the following countries: 

Cameroon, Cote d’Ivoire, Guinea, and 

Guinea-Bissau to support the responses 

of the CDC to the outbreak of Ebola 

virus in West Africa. This funding will 

enable the U.S. to provide unified 

mobilization to address a crisis of this 

magnitude. CDC will continue to build 

partnerships and strengthen existing 

projects to respond to Ebola. CDC and 

its partners will help to address the 

need for surveillance, detection, 

coordination, response, and increase 

eligible governments’ capacity to 

respond to the Ebola outbreak. 

Award Information 

Type of Award: Expansion 

Supplement. 

Approximate Total Current Fiscal 

Year Funding: $1,100,000. 

Anticipated Number of Awards: One. 

Fiscal Year Funds: 2015. 

Anticipated Award Date: December 1, 

2014. 

Application Selection Process: 

Funding will be awarded to applicant 

based on results from the technical 

review recommendation. 

Dated: November 6, 2014. 

Ron A. Otten, 

Acting Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2014–26799 Filed 11–7–14; 11:15 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Objective Work Plan (OWP) and 

Objective Progress Report (OPR). 

OMB No.: 0970–0429. 

Description: Content and formatting 

changes are being made to the OPR and 

OWP. The information in OPR is 

currently collected on quarterly basis to 

monitor the performance of grantees and 

better gauge grantee progress. The OWP 

is used by applicants when they submit 

their proposals and then by grantees to 

monitor their projects once the award is 

made by ANA. ANA has determined 

that the requirement for ANA grantees 

to submit information about the project 

activities on quarterly basis creates 

undue burden for Grantees. Therefore, 

ANA has reformatted the OPR to require 

Grantees submit semi-annual reports 

instead of quarterly report. This will 

reduce the administrative burden on 

Grantees, especially the smaller 

organizations. The majority of content 

being requested from the grantees 

essentially remain same except for the 

frequency of reporting. 

OPR: The following are proposed 

content changes to the document: 

Grantee Information: Report 

Frequency—This section of OPR will be 

reformatted to request semi-annual or 

final project data instead of quarterly 

information. The other sections of the 

document with reference to ‘‘quarterly’’ 

information will be changed to reflect 

the shift from four-times a year 

reporting requirement to twice per year. 

Objective Work Plan Update: Content 

remains the same. No changes are 

proposed for this section of the OPR. 

Impact indicator: Current Status of 

Expected Results and Current Status of 

Expected Benefits which are reported 

separately on the OPR will be combined 


tkelley on DSK3SPTVN1PROD with NOTICES